Document is current
Any future updates will be listed below
-
Authors
Hastie, Kathryn M. https://orcid.org/0000-0002-3406-1210
Salie, Zhe Li https://orcid.org/0000-0003-2063-1013
Ke, Zunlong
Halfmann, Peter J. https://orcid.org/0000-0002-1648-1625
DeWald, Lisa Evans
McArdle, Sara https://orcid.org/0000-0003-3795-3772
Grinyó, Ariadna https://orcid.org/0000-0003-0185-2734
Davidson, Edgar
Schendel, Sharon L. https://orcid.org/0000-0002-5062-7261
Hariharan, Chitra
Norris, Michael J. https://orcid.org/0000-0002-8325-5257
Yu, Xiaoying https://orcid.org/0000-0002-6778-5004
Chennareddy, Chakravarthy
Xiong, Xiaoli https://orcid.org/0000-0002-4632-9122
Heinrich, Megan https://orcid.org/0000-0002-3079-6500
Holbrook, Michael R. https://orcid.org/0000-0002-0824-2667
Doranz, Benjamin https://orcid.org/0000-0002-8245-3083
Crozier, Ian https://orcid.org/0000-0003-2485-4011
Kawaoka, Yoshihiro https://orcid.org/0000-0001-5061-8296
Branco, Luis M.
Kuhn, Jens H. https://orcid.org/0000-0002-7800-6045
Briggs, John A. G. https://orcid.org/0000-0003-3990-6910
Worwa, Gabriella
Davis, Carl W.
Ahmed, Rafi https://orcid.org/0000-0002-9591-2621
Saphire, Erica Ollmann https://orcid.org/0000-0002-1206-7451
- License Information
-
More Information
Article History
Received: 19 December 2023
Accepted: 17 January 2025
First Online: 3 February 2025
Competing interests
: A.G., E.D., and B.J.D. are employees of Integral Molecular, and B.J.D. is a shareholder in that company. The remaining authors declare no competing interests.
: Animal exposure and treatment experiments using infectious EBOV were performed in registered an ethics accredited biosafety level 4 (BSL-4) laboratories with appropriate approvals.
